Cancer immunotherapy: Car T Cell Technology

A type of treatment in which a patient’s T cells (a type of immune cell) are altered in the laboratory so they will bind to cancer cells and destroy them. Blood from a vein in the patient’s arm flows through a tube to an apheresis machine (not shown), which eliminates the white blood cells, including the T cells, and directs the rest of the blood back to the patient. Then, the gene for a special receptor named a chimeric antigen receptor (CAR) is introduced into the T cells in the laboratory. Millions of the CAR T cells are developed in the laboratory and then given to the patient by infusion. The CAR T cells are able to bind to an antigen on the cancer cells and destroy them.

  • CAR-T cell therapy in acute lymphoblastic leukaemia
  • CAR-T cells therapy in chronic lymphocytic leukaemia
  • CAR-T cell in multiple myeloma

Related Conference of Cancer immunotherapy: Car T Cell Technology

April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 21-22, 2025

24th International Conference on Genomics and Molecular Biology

Aix-en-Provence, France
July 21-22, 2025

11th World Congress on Anesthesia and Critical Care

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France
August 25-26, 2025

8th International Conference on Community Nursing and Public Health

Singapore City, Singapore
September 22-23, 2025

39th International Conference on Cancer Science & Therapy

Amsterdam, Netherlands
October 16-17, 2025

19th International Conference on Pathology and Laboratory Medicine

Aix-en-Provence, France
November 03-04, 2025

5th World Medicine Congress

Rome, Italy

Cancer immunotherapy: Car T Cell Technology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in